BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Liu T, Li X, Sheng H, Ma X, Hao L. Ferroptosis-Inducing Nanomedicine for Cancer Therapy. Front Pharmacol 2021;12:735965. [PMID: 34987385 DOI: 10.3389/fphar.2021.735965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng X, Lu Z, Zhang L, Wang Z. A pH/ATP-responsive nanomedicine via disrupting multipath homeostasis of ferroptosis for enhanced cancer therapy. Chemical Engineering Journal 2023. [DOI: 10.1016/j.cej.2023.141313] [Reference Citation Analysis]
2 Kavvadas E. C3d(g), iron nanoparticles, hemin and cytochrome c may induce oxidative cytotoxicity in tumors and reduce tumor-associated myeloid cells-mediated immunosuppression. Medical Hypotheses 2022;167:110944. [DOI: 10.1016/j.mehy.2022.110944] [Reference Citation Analysis]
3 Cheng K, Guo Q, Shen Z, Yang W, Zhou Y, Sun Z, Yao X, Wu H. Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field. Front Oncol 2022;12:948389. [DOI: 10.3389/fonc.2022.948389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yu H, Han Z, Chen C, Zhang L. Nanomaterials as Novel Biomarkers for Cancer Nanotheranostics: State of the Art. Biotechnology - Biosensors, Biomaterials and Tissue Engineering - Annual Volume 2022 [Working Title] 2022. [DOI: 10.5772/intechopen.105700] [Reference Citation Analysis]
5 Zhang L, Cai H. Cancer Immunotherapy and Cytotoxicity: Current Advances and Challenges. Cytotoxicity [Working Title] 2022. [DOI: 10.5772/intechopen.105184] [Reference Citation Analysis]